An Effective Delivery System of Sitagliptin Using Optimized Mucoadhesive Nanoparticles
Sitagliptin (MK-0431), is a potent oral hypoglycemic drug that is used for treating type 2 diabetes mellitus. However, the short half-life of sitagliptin requires patients to take a high dose of 50 mg twice per day, and the fraction of sitagliptin reversibly bound to plasma proteins is as low as 38%...
Main Authors: | Afzal Haq Asif, Sree Harsha, Niranjan Hodalur Puttaswamy, Bandar E. Al-Dhubiab |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-05-01
|
Series: | Applied Sciences |
Subjects: | |
Online Access: | http://www.mdpi.com/2076-3417/8/6/861 |
Similar Items
-
Sitagliptin induced acute pancreatitis: Case report and brief review of literature
by: Unmesh Takalkar, et al.
Published: (2019-02-01) -
Chitosan Nanoparticles as a Mucoadhesive Drug Delivery System for Ocular Administration
by: Mariana M. Silva, et al.
Published: (2017-12-01) -
Mucoadhesive drug delivery systems
by: Rahamatullah Shaikh, et al.
Published: (2011-01-01) -
Acrylated Chitosan Nanoparticles with Enhanced Mucoadhesion
by: Shaked Eliyahu, et al.
Published: (2018-01-01) -
Optimization of Thiolated Chitosan Nanoparticles for the Enhancement of in Vivo Hypoglycemic Efficacy of Sitagliptin in Streptozotocin-Induced Diabetic Rats
by: Kousalya Prabahar, et al.
Published: (2020-03-01)